alstria office REIT-AG
alstria office REIT AG is the leading real-estate operator focusing solely on German office property in selected German markets. Our strategy is based on the ownership and an active management of our properties throughout their entire life cycle, strong added-value services to our customers and deep knowledge of the markets in which we operate. alstria strives for sustainable long-term value crea… Read more
alstria office REIT-AG (AOX) - Total Liabilities
Latest total liabilities as of March 2025: €2.93 Billion EUR
Based on the latest financial reports, alstria office REIT-AG (AOX) has total liabilities worth €2.93 Billion EUR as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
alstria office REIT-AG - Total Liabilities Trend (2006–2024)
This chart illustrates how alstria office REIT-AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
alstria office REIT-AG Competitors by Total Liabilities
The table below lists competitors of alstria office REIT-AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Beacon Financial Corporation
NYSE:BBT
|
USA | $20.72 Billion |
|
Energizer Holdings Inc
NYSE:ENR
|
USA | $4.30 Billion |
|
Yancoal Australia Ltd
PINK:YACAF
|
USA | $2.98 Billion |
|
Keli Sensing Technology Ningbo Co Ltd
SHG:603662
|
China | CN¥1.36 Billion |
|
Shanghai Zijiang Enterprise Group Co Ltd
SHG:600210
|
China | CN¥6.45 Billion |
|
K.P.R. Mill Limited
NSE:KPRMILL
|
India | ₹7.34 Billion |
|
Chengdu Olymvax Biopharmaceuticals Inc. A
SHG:688319
|
China | CN¥976.63 Million |
|
Mesoblast Limited
F:LWB
|
Germany | €187.24 Million |
Liability Composition Analysis (2006–2024)
This chart breaks down alstria office REIT-AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.90 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how alstria office REIT-AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for alstria office REIT-AG (2006–2024)
The table below shows the annual total liabilities of alstria office REIT-AG from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €2.84 Billion | +8.48% |
| 2023-12-31 | €2.62 Billion | +1.06% |
| 2022-12-31 | €2.59 Billion | +38.83% |
| 2021-12-31 | €1.87 Billion | +1.59% |
| 2020-12-31 | €1.84 Billion | -0.85% |
| 2019-12-31 | €1.85 Billion | +23.82% |
| 2018-12-31 | €1.50 Billion | -8.12% |
| 2017-12-31 | €1.63 Billion | -1.50% |
| 2016-12-31 | €1.65 Billion | -24.57% |
| 2015-12-31 | €2.19 Billion | +137.66% |
| 2014-12-31 | €922.71 Million | -2.00% |
| 2013-12-31 | €941.57 Million | -1.68% |
| 2012-12-31 | €957.61 Million | +4.26% |
| 2011-12-31 | €918.44 Million | +8.06% |
| 2010-12-31 | €849.93 Million | -24.91% |
| 2009-12-31 | €1.13 Billion | -1.04% |
| 2008-12-31 | €1.14 Billion | +18.57% |
| 2007-12-31 | €964.64 Million | +1.85% |
| 2006-12-31 | €947.08 Million | -- |